BDgene 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BD311 / BDgene
NCT05099094: VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Recruiting
1
18
RoW
BD311
Shanghai BDgene Co., Ltd., Eye & ENT Hospital of Fudan University
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
09/23
09/23
BD111 / BDgene
NCT06474442: A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Not yet recruiting
2
40
RoW
BD111 Injection (investigational new drug), BD111 Lentivirus-like particles, also called HSV-1-erasing lentiviral particles (HELP), Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Eye gel+Valacilovir Tablets+Prednisolone Acetate Eye Drops
Shanghai BDgene Co., Ltd.
Herpes Simplex Virus Type I Stromal Keratitis
12/25
12/26
NCT06474416: A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Recruiting
1
16
RoW
BD111 Injection (Investigative New Drug), BD111 Lentivirus-like particles, HSV-1-erasing lentiviral particles, HELP, Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Ophthalmic Gel, Valacyclovir Hydrochloride Tablets, Prednisolone Acetate Ophthalmic Suspension
Shanghai BDgene Co., Ltd.
Herpes Simplex Virus Type I Stromal Keratitis
09/25
09/25

Download Options